Session date: 
Friday, June 10, 2016 - 8:30am to 9:30am
Location: 
Children's Hopsital of Wisconsin
9000 W. 92nd Street
Briggs and Stratton Auditorium (second floor)
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 
This educational activity is designed to highlight a new innovation, discovery, or update in medical science with an emphasis on how it applies to diagnosis, treatment, or outcomes in clinical care of the pediatric patient. The idea is to explain any basic science in such a way that will be educational and interesting to a general clinician; provide an update on clinical guidelines for diagnosis and treatment using evidence based medicine when applicable. This lecture can bring to the forefront new practice guidelines from the experts.
 
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
 
Target audience: 

Pediatrician, Psychologist, Fellow, Resident, Nurse, Other

Learning objectives: 

Participants will be able to:

Educational Objective (s): 

  1.  Appreciate the national health goals in DVT prevention and how they apply to Children’s Hospitals
  2.  Understand the mechanism of novel oral anticoagulants and the potential role that these agents will play in pediatrics
  3.  Gain confidence with “clot busting” interventional techniques to DVT in children and adolescents including indications, methods, expected outcomes and potential complications

Faculty & credentials: 
Planning Committee: 
Cindy Pan, MD
Robert Lane, MD
Matthew Jandrisevits, PhD
 
All persons in control of content have NO relevant financial relationships to disclose with the following exception:
 

Presenter: 

Marilyn J. Manco-Johnson, MD, Director, Mountain States Regional Hemophilia and Thrombosis Center; Professor of Pediatrics, University of Colorado, Anschutz Medical Campus

Bayer, Research Funds, PI and Bayer, Nordich Honorarium, Advisory Board

CME Coordinator Contact Information

Name: 
Karen Knippel
Phone number: 
+1 (414) 337-7451